Overall survival (OS) of real-world patients with stage IIIb/IV non-small cell lung cancer (NSCLC) initiating epidermal growth factor receptor (EGFR) targeted tyrosine kinase inhibitors (TKI) as first-line treatment in England. (January 2019)

Record Type:: Journal Article
Title:: Overall survival (OS) of real-world patients with stage IIIb/IV non-small cell lung cancer (NSCLC) initiating epidermal growth factor receptor (EGFR) targeted tyrosine kinase inhibitors (TKI) as first-line treatment in England. (January 2019)
Main Title:: Overall survival (OS) of real-world patients with stage IIIb/IV non-small cell lung cancer (NSCLC) initiating epidermal growth factor receptor (EGFR) targeted tyrosine kinase inhibitors (TKI) as first-line treatment in England
Authors:: Rigney, U.
Lock, K.
Chen, C.
Escriu, C.
Abstract:
Is Part Of:: Lung cancer. Volume 127(2019)Supplement 1
Journal:: Lung cancer
Issue:: Volume 127(2019)Supplement 1
Issue Display:: Volume 127, Issue 1 (2019)
Year:: 2019
Volume:: 127
Issue:: 1
Issue Sort Value:: 2019-0127-0001-0000
Page Start:: S40
Page End:
Publication Date:: 2019-01
Subjects:: Lungs -- Cancer -- Periodicals
Lung Neoplasms -- Abstracts
Lung Neoplasms -- Periodicals
Poumons -- Cancer -- Périodiques
Lungs -- Cancer
Periodicals
Electronic journals
Electronic journals
616.99424
Journal URLs:: http://www.sciencedirect.com/science/journal/01695002 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01695002 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01695002 ↗
http://www.lungcancerjournal.info/issues ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0169-5002(19)30138-2 ↗
Languages:: English
ISSNs:: 0169-5002
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 5307.245000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 9712.xml